Frontiers in Psychology (Oct 2021)
Cognitive Impairment in Late-Life Depression: A Comparative Study of Healthy Older People, Late-Life Depression, and Mild Alzheimer's Disease Using Multivariate Base Rates of Low Scores
- Caroline Masse,
- Caroline Masse,
- Pierre Vandel,
- Pierre Vandel,
- Pierre Vandel,
- Pierre Vandel,
- Géraldine Sylvestre,
- Géraldine Sylvestre,
- Nicolas Noiret,
- Djamila Bennabi,
- Djamila Bennabi,
- Frédéric Mauny,
- Frédéric Mauny,
- Marc Puyraveau,
- Yoan Barsznica,
- Yoan Barsznica,
- Yoan Barsznica,
- Jonathan Dartevelle,
- Agatha Meyer,
- Mickaël Binetruy,
- Marie Lavaux,
- Ilham Ryff,
- Ilham Ryff,
- Julie Giustiniani,
- Julie Giustiniani,
- Eloi Magnin,
- Eloi Magnin,
- Jean Galmiche,
- Emmanuel Haffen,
- Emmanuel Haffen,
- Emmanuel Haffen,
- Gilles Chopard,
- Gilles Chopard,
- Gilles Chopard,
- Gilles Chopard
Affiliations
- Caroline Masse
- Department of Clinical Psychiatry, Besançon University Hospital, Besançon, France
- Caroline Masse
- Laboratory of Neurosciences and Cognitive Psychology, University of Bourgogne Franche-Comté, Besançon, France
- Pierre Vandel
- Department of Clinical Psychiatry, Besançon University Hospital, Besançon, France
- Pierre Vandel
- Laboratory of Neurosciences and Cognitive Psychology, University of Bourgogne Franche-Comté, Besançon, France
- Pierre Vandel
- Association for the Development of Applied Neuropsychology, Besançon, France
- Pierre Vandel
- Clinical Investigation Center 1431-INSERM, Besançon University Hospital, Besançon, France
- Géraldine Sylvestre
- Association for the Development of Applied Neuropsychology, Besançon, France
- Géraldine Sylvestre
- Department of Neurology, Memory Resource and Research Center (CM2R), Besançon University Hospital, Besançon, France
- Nicolas Noiret
- Research Centre on Cognition and Learning (CeRCA), UMR 7295 CNRS, University of Poitiers and University of Tours, Poitiers, France
- Djamila Bennabi
- Department of Clinical Psychiatry, Besançon University Hospital, Besançon, France
- Djamila Bennabi
- Laboratory of Neurosciences and Cognitive Psychology, University of Bourgogne Franche-Comté, Besançon, France
- Frédéric Mauny
- Methodology Unit, uMETh, Clinical Investigation Center 1431-INSERM, Besançon, France
- Frédéric Mauny
- Laboratory of Chrono-Environnement, UMR 6249 CNRS, University of Bourgogne Franche-Comté, Besançon, France
- Marc Puyraveau
- Methodology Unit, uMETh, Clinical Investigation Center 1431-INSERM, Besançon, France
- Yoan Barsznica
- Department of Clinical Psychiatry, Besançon University Hospital, Besançon, France
- Yoan Barsznica
- Laboratory of Neurosciences and Cognitive Psychology, University of Bourgogne Franche-Comté, Besançon, France
- Yoan Barsznica
- Department of Neurology, Memory Resource and Research Center (CM2R), Besançon University Hospital, Besançon, France
- Jonathan Dartevelle
- Association for the Development of Applied Neuropsychology, Besançon, France
- Agatha Meyer
- Association for the Development of Applied Neuropsychology, Besançon, France
- Mickaël Binetruy
- Association for the Development of Applied Neuropsychology, Besançon, France
- Marie Lavaux
- Association for the Development of Applied Neuropsychology, Besançon, France
- Ilham Ryff
- Department of Clinical Psychiatry, Besançon University Hospital, Besançon, France
- Ilham Ryff
- Department of Neurology, Memory Resource and Research Center (CM2R), Besançon University Hospital, Besançon, France
- Julie Giustiniani
- Department of Clinical Psychiatry, Besançon University Hospital, Besançon, France
- Julie Giustiniani
- Laboratory of Neurosciences and Cognitive Psychology, University of Bourgogne Franche-Comté, Besançon, France
- Eloi Magnin
- Laboratory of Neurosciences and Cognitive Psychology, University of Bourgogne Franche-Comté, Besançon, France
- Eloi Magnin
- Department of Neurology, Memory Resource and Research Center (CM2R), Besançon University Hospital, Besançon, France
- Jean Galmiche
- Association for the Development of Applied Neuropsychology, Besançon, France
- Emmanuel Haffen
- Department of Clinical Psychiatry, Besançon University Hospital, Besançon, France
- Emmanuel Haffen
- Laboratory of Neurosciences and Cognitive Psychology, University of Bourgogne Franche-Comté, Besançon, France
- Emmanuel Haffen
- Clinical Investigation Center 1431-INSERM, Besançon University Hospital, Besançon, France
- Gilles Chopard
- Department of Clinical Psychiatry, Besançon University Hospital, Besançon, France
- Gilles Chopard
- Laboratory of Neurosciences and Cognitive Psychology, University of Bourgogne Franche-Comté, Besançon, France
- Gilles Chopard
- Association for the Development of Applied Neuropsychology, Besançon, France
- Gilles Chopard
- Department of Neurology, Memory Resource and Research Center (CM2R), Besançon University Hospital, Besançon, France
- DOI
- https://doi.org/10.3389/fpsyg.2021.724731
- Journal volume & issue
-
Vol. 12
Abstract
Late-Life Depression (LLD) is often associated with cognitive impairment. However, distinction between cognitive impairment due to LLD and those due to normal aging or mild Alzheimer's Disease (AD) remain difficult. The aim of this study was to present and compare the multivariate base rates of low scores in LLD, mild AD, and healthy control groups on a battery of neuropsychological tests. Participants (ages 60–89) were 352 older healthy adults, 390 patients with LLD, and 234 patients with mild AD (i.e., MMSE ≥ 20). Multivariate base rates of low scores (i.e., ≤ 5th percentile) were calculated for each participant group within different cognitive domains (verbal episodic memory, executive skills, mental processing speed, constructional praxis, and language/semantic memory). Obtaining at least one low score was relatively common in healthy older people controls (from 9.4 to 17.6%), and may thus result in a large number of false positives. By contrast, having at least two low scores was unusual (from 0.3 to 4.6%) and seems to be a more reliable criterion for identifying cognitive impairment in LLD. Having at least three low memory scores was poorly associated with LLD (5.9%) compared to mild AD (76.1%) and may provide a useful way to differentiate between these two conditions [χ(1)2 = 329.8, p < 0.001; Odds Ratio = 50.7, 95% CI = 38.2–77.5]. The multivariate base rate information about low scores in healthy older people and mild AD may help clinicians to identify cognitive impairments in LLD patients, improve the clinical decision-making, and target those who require regular cognitive and clinical follow-up.
Keywords